Javascript must be enabled to continue!
P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
View through CrossRef
Nucleotides mediate intercellular communication by activating purinergic receptors and take part in various physiological and pathological processes. Abnormal purinergic signaling plays important roles in malignant progression. P2X7, which belongs to the P2X family of purinergic receptors, is abnormally expressed in various types of malignancies including leukemia. However, its role and molecular mechanism in leukemia have not been elucidated. Here, we analyzed the correlation between P2X7 expression and AML clinical outcome; explored the role and mechanism of P2X7 in AML progression by using mouse acute myeloid leukemia (AML), nude mouse xenograft and patient-derived xenograft models. High levels of P2X7 expression were correlated with worse survival in AML. P2X7 was highly expressed in MLL-rearranged AML. Furthermore, P2X7 accelerated the progression of MLL-rearranged AML by both promoting cell proliferation and increasing leukemia stem cell (LSC) levels. Moreover, P2X7 caused upregulation of Pbx3 accounts for its pro-leukemic effects. The P2X7-Pbx3 pathway might also contribute to the progression of other types of leukemia as well as solid tumors with high levels of P2X7 expression. Our study provides new insights into the malignant progression caused by abnormal purinergic signaling.
Ferrata Storti Foundation (Haematologica)
Title: P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3
Description:
Nucleotides mediate intercellular communication by activating purinergic receptors and take part in various physiological and pathological processes.
Abnormal purinergic signaling plays important roles in malignant progression.
P2X7, which belongs to the P2X family of purinergic receptors, is abnormally expressed in various types of malignancies including leukemia.
However, its role and molecular mechanism in leukemia have not been elucidated.
Here, we analyzed the correlation between P2X7 expression and AML clinical outcome; explored the role and mechanism of P2X7 in AML progression by using mouse acute myeloid leukemia (AML), nude mouse xenograft and patient-derived xenograft models.
High levels of P2X7 expression were correlated with worse survival in AML.
P2X7 was highly expressed in MLL-rearranged AML.
Furthermore, P2X7 accelerated the progression of MLL-rearranged AML by both promoting cell proliferation and increasing leukemia stem cell (LSC) levels.
Moreover, P2X7 caused upregulation of Pbx3 accounts for its pro-leukemic effects.
The P2X7-Pbx3 pathway might also contribute to the progression of other types of leukemia as well as solid tumors with high levels of P2X7 expression.
Our study provides new insights into the malignant progression caused by abnormal purinergic signaling.
Related Results
Histone Profiling of Normal B-Precursors and Primary Pre-B Acute Lymphoblastic Leukemia Reveals Distinct Aberrant Histone Codes In MLL-Rearranged Vs. Wild Type MLL Leukemias That Correlate with Differential Expression of Key MLL Target Genes
Histone Profiling of Normal B-Precursors and Primary Pre-B Acute Lymphoblastic Leukemia Reveals Distinct Aberrant Histone Codes In MLL-Rearranged Vs. Wild Type MLL Leukemias That Correlate with Differential Expression of Key MLL Target Genes
Abstract 2503
Epigenetic regulation of gene transcription is mediated both by methylation of DNA CpG islands and the local configuration of chromatin, which is dynam...
Abstract 3849: The partial tandem duplication of Mll (Mll PTD) is a gain-of-function in the absence of Mll wildtype (Mll WT) in adult mouse hematopoiesis.
Abstract 3849: The partial tandem duplication of Mll (Mll PTD) is a gain-of-function in the absence of Mll wildtype (Mll WT) in adult mouse hematopoiesis.
Abstract
Cytogenetically normal acute myeloid leukemia (CN AML) patients with a MLL PTD have a poor prognosis compared to CN AML patients with MLL WT. We previously ...
Abstract 3550: The ENL YEATS domain links leukemic stem cell frequency and enhances YEATS inhibitor sensitivity in MLL-ENL leukemias
Abstract 3550: The ENL YEATS domain links leukemic stem cell frequency and enhances YEATS inhibitor sensitivity in MLL-ENL leukemias
Abstract
Chromosome 11q23 translocations are present in ~10% of acute leukemia, which generate the oncogenic MLL fusion (MLL-r hereinafter) proteins and drive a subs...
Clonal Expansion of MLL-ELL Rearrangement without Relapse of Leukemia after Treatment of MLL-ELL Positive AML; with a Rare Breakpoint in MLL Gene.
Clonal Expansion of MLL-ELL Rearrangement without Relapse of Leukemia after Treatment of MLL-ELL Positive AML; with a Rare Breakpoint in MLL Gene.
Abstract
Introduction The MLL gene located on 11q13 is a frequent target of chromosomal translocation and induces acute leukemia with a poor prognosis. The ELL gene,...
Using Genome Engineering To Prospectively Investigate The Pathogenesis Of MLL Translocations In Infant Acute Lymphoblastic Leukemia
Using Genome Engineering To Prospectively Investigate The Pathogenesis Of MLL Translocations In Infant Acute Lymphoblastic Leukemia
Abstract
Introduction
Chromosomal rearrangements involving the MLL gene occur in both primary and treatment-related leukemias an...
Molecular Basis of Menin-MLL Interaction: Implication for Targeted Therapies in MLL Leukemias.
Molecular Basis of Menin-MLL Interaction: Implication for Targeted Therapies in MLL Leukemias.
Abstract
Abstract 3775
Poster Board III-711
Chromosomal translocations that affect the proto-oncogene MLL (Mixed Lineage Leukemia) occu...
The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.
The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.
Abstract
Mixed Lineage Leukemia (MLL) is a histone H3K4 methyltransferase that is rearranged in both acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL). ...
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract
Translocation breakpoints involving the MLL gene linked to Infant Acute Leukemia (IAL) and therapy related acute leukemia (tAL) are tightly clustered betwee...

